About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Baltimore | 13,709 Studies Near You

Clinical TrialsBaltimore

Clinical Trials in Baltimore

Discover 13,709 clinical trials near Baltimore, Maryland. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5441-5460 of 13,709 trials

Enrolling by invitationMulticenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes DiseaseLegg-Calvé-Perthes disease is a childhood hip disorder which is common enough to be a significant public health problem (affects 1 in 740 boys between ages 0-14), but uncommon…NCT02040714·Birmingham, Alabama and 45 others

Find Trials by Condition in Baltimore

Breast Cancerin Baltimore Lung Cancerin Baltimore Prostate Cancerin Baltimore Colorectal Cancerin Baltimore Melanomain Baltimore Leukemiain Baltimore Lymphomain Baltimore Pancreatic Cancerin Baltimore Ovarian Cancerin Baltimore Brain Cancerin Baltimore

Data from ClinicalTrials.govTerms

RecruitingA Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck CancerThe purpose of this study is to compare anti-tumor activity of amivantamab in addition to pembrolizumab and carboplatin versus pembrolizumab, 5-fluorouracil (FU), and platinum…NCT07276399·Chandler, Arizona and 202 others

CompletedPhase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease AloneTo assess a new drug, BAY94-8862, given orally at different doses, to evaluate whether it was safe and can help the well-being of patients with worsening chronic heart failure and…NCT01807221·Birmingham, Alabama and 171 others

CompletedConfocal Endomicroscopy for Barrett's EsophagusThe purpose of this study is to determine if confocal laser endomicroscopy (CLE) can improve detection of Barrett's esophagus, dysplasia, and early esophageal cancer.NCT00487695·Baltimore, Maryland

CompletedPharmacodynamic/Pharmacokinetic Study of AQW051 in SchizophreniaPart 1 of the study will assess the enhancement of task-related brain activation (BOLD response) in key brain areas in schizophrenia during the performance of working memory…NCT00825539·Los Angeles, California and 6 others

CompletedEvaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell PatientsThe purpose of this study is to evaluate the performance of the Spectra Optia system red blood cell exchange (RBCx) protocols (exchange and depletion/exchange) in study…NCT01736657·Birmingham, Alabama and 4 others

CompletedMortality Reduction After Oral Azithromycin: Mortality StudyOur long-term goal is to more precisely define the role of mass azithromycin treatments as an intervention for reducing childhood mortality.NCT02047981·San Francisco, California and 5 others

CompletedSafety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver ImpairmentPrimary Objectives: * To determine the maximum tolerated dose (MTD) and safety of Cabazitaxel when administered to advanced solid tumor patients with varying degrees of hepatic…NCT01140607·La Jolla, California and 13 others

RecruitingA Study to Investigate the Safety and PK of VH4770359 in Healthy ParticipantsVH4770359 (also known as GSK4770359) is an antiretroviral compound.NCT07525544·Baltimore, Maryland

RecruitingLIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisThis study is open to adults who are at least 18 years old living with obesity and have: * a confirmed liver disease called non-alcoholic steatohepatitis (NASH)/metabolic…NCT06632444·Birmingham, Alabama and 530 others

CompletedThe Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected WomenThe purpose of this study is to see how often human papillomavirus (HPV) occurs in HIV-infected women who have not taken anti-HIV drugs and to learn whether taking anti-HIV drugs…NCT00006444·Birmingham, Alabama and 50 others

CompletedThe Tobacco, Alcohol, Prescription Medication and Other Substances ToolThe purpose of the study is to develop and validate a questionnaire to screen and assess adult primary care patients for tobacco, alcohol, prescription drug, and drug use and…NCT02110693·Baltimore, Maryland and 3 others

CompletedEvaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)The purpose of this study is to evaluate whether MST-188 can reduce the duration of vaso-occlusive crisis (VOC) in subjects with sickle cell disease.NCT01737814·Mobile, Alabama and 71 others

CompletedVinorelbine in Treating Children With Recurrent or Refractory CancersRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003234·Birmingham, Alabama and 227 others

Active not recruitingA Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk RhabdomyosarcomaThis phase III trial compares the safety and effect of adding vinorelbine to vincristine, dactinomycin, and cyclophosphamide (VAC) for the treatment of patients with high risk…NCT04994132·Birmingham, Alabama and 249 others

Active not recruitingHeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal TumorsThis is a prospective randomized clinical trial, to determine whether dose-intensive tandem Consolidation, in a randomized comparison with single cycle Consolidation, provides an…NCT02875314·Birmingham, Alabama and 61 others

CompletedStudy of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)The purpose of the study is to compare the clinical benefit, as measured by duration of overall survival, of Nivolumab vs. Everolimus in subjects with advanced or metastatic…NCT01668784·Fayetteville, Arkansas and 167 others

CompletedStudy of KBP-7072 in Healthy Male and Female SubjectsThis is a double-blind, randomized, placebo-controlled, single and multiple IV dose study conducted in two parts.NCT05507463·Baltimore, Maryland

Active not recruitingTesting the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)This phase II/III Lung-MAP trial studies how well immunotherapy treatment with N-803 (ALT-803) and pembrolizumab working in treating patients with non-small cell lung cancer that…NCT05096663·Birmingham, Alabama and 349 others

CompletedSarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated DyskinesiaThe purpose of this study is to test multiple doses of sarizotan to establish a dose with maximal safety and efficacy for treating treatment associated dyskinesia in Parkinson's…NCT00105521·Phoenix, Arizona and 31 others

PreviousPage 273 of 686Next

Diabetes

in Baltimore

Heart Diseasein Baltimore